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Sacrococcygeal teratoma: management and
outcomes
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Background/aim Sacrococcygeal teratomas are the most
common tumor during the neonatal period. They are either
benign (mature) or malignant (immature, composed of
embryonic elements). This retrospective study aims at
reviewing our experience in management and outcome of
this pathology during the period from January 2008 to
November 2013.
Patients and methods Charts were designed to collect
the following data: the age at presentation, sex, clinical
presentation, associated anomalies, Altman’s
classification, investigations, management modality, tumor
histology with respect to type and resection margins,
outcome of treatment, and bowel or urinary complications.
Results A total of 20 patients were included in this study.
There were six male patients and 14 female patients. Ten
patients were Altman type I, seven were type II, one was
type III, and two were type IV. Surgical intervention was
carried out using a posterior sacral approach in 17 patients
(all type I and II patients) or combined abdominal and
posterior sacral approaches in the remaining three patients
(types III and IV). Recurrence occurred in two patients;
these were types III and IV. We had one mortality. Two
patients reported involuntary bowel movements, two
reported frequent soiling, and five reported constipation.
Conclusion Awareness about this pathology among
practitioners is essential and would have avoided
complications in this series. Early diagnosis and complete
excision with removal of the coccyx is associated with
good prognosis. Recurrence is related to tumor spillage
during excision. Long-term lower gastrointestinal problems
(constipation, fecal soiling) correlate with Altman’s
classification of the tumor. Ann Pediatr Surg 10:72–77 c
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Introduction
Sacrococcygeal teratomas (SCTs) are congenital neo-
plasms that arise from the coccyx and comprise tissues
derived from all three germ layers. They are believed to
arise from embryologically multipotent cells within
Hensen node, a remnant of the primitive streak in the
coccygeal region [1].
Although it is the most common tumor during the
neonatal period, SCTs are rare with an incidence of
approximately one in 35 000–40 000 live births. Female
individuals are affected more frequently with a female-to-
male ratio of almost 4 : 1 [2,3]; 18% of these infants have
additional congenital anomalies [4].
SCTs are either benign (mature) or malignant (immature,
composed of embryonic elements). Mature teratomas are
more common in both neonates (68%) and older children
(73%) [5].
Altman et al. [6] have classified SCTs into four groups.
Type I tumors are almost exclusively exterior with
minimal pelvic component; type II tumors have a
significant pelvic component (hour-glass pattern); type
III tumors have a larger proportion of intra-abdominal and
intrapelvic component than the external component; and
type IV tumors are exclusively presacral with no external
component. Altman and colleagues also reported that
type I tumors were rarely malignant.
SCT can be diagnosed during antenatal ultrasonography.
Polyhydramnios is found in up to 20% of cases [7]. They
have a wide variety of clinical presentations depending on
their size, vascularity, and degree of mass effect upon
adjacent structures [8].
Before 2 months of age, most of these lesions are benign,
and surgical extirpation with coccygectomy can be
accomplished with relatively low morbidity and mortal-
ity [9,10]. Excision of the coccyx is mandatory in all cases.
Failure to remove the coccyx results in 30–40% recur-
rence rate, with a higher probability of malignancy [11].
The use of a-fetoprotein (AFP) as a tumor marker is well
established, and persistent elevated level may indicate a
residual tumor, recurrence, or malignant degenera-
tion [12]. However, it should be performed with caution
in infants because its levels are normally elevated in the
first 8 months of life [13]. The mean time required for
AFP to be normalized after SCT resection is about 9
months [14].
Recurrence after resection varies from 2 to 35%. This may
result from incomplete surgical excision with the
presence of microscopic residues, nonresection of the
entire coccyx, and/or tumor spillage [15,16].
Although the postnatal mortality of SCTs is low [17],
prenatally diagnosed SCTs can be associated with higher
mortality [18]. Outcomes after surgical resection during
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the neonatal period are generally favorable, although
tumor recurrence with malignant transformation can
occur in 10–20% of patients [19].
Although severe distal motor deficits are unusual after
resection, other neurologic sequelae can be commonly
observed and include subtle abnormalities in gait as well
as fecal and/or urinary dysfunction in up to 50% of
patients [20].
This study was a retrospective file review for cases of
SCTs at our institution regarding presentation, complica-
tions, management, and outcome.
Patients and methods
Records of all cases of SCTs seen at the Pediatric Surgical
Unit in Tanta University Hospitals and affiliated Hospi-
tals during the period from January 2008 to November
2013 were reviewed.
Special charts were designed to retrieve the following
data from records: the age at presentation, sex, clinical
presentation, associated anomalies, Altman’s classifica-
tion, investigations, management modality, tumor histol-
ogy with respect to type and resection margins, and
outcome of treatment.
The data retrieved from the follow-up visits included:
wound complications as disruption or necrosis, any masses
at the resection site, careful PR, stabilization of cardiac
condition after excision of the huge highly vascular cases,
and serum AFP evaluation and pelvic ultrasound every
3 months.
All patients operated upon from 2008 to 2010 (3–5 years
of age) were contacted to fill in a special chart evaluating
urinary incontinence, soiling, and constipation. Questions
were categorized into parameters – (i) involuntary bowel
control (inability to feel the urge to use the toilet to have
a bowel movement, inability to verbalize it, and to hold
the bowel movement until the patient reaches the
bathroom); (ii) soiling; (iii) constipation; and (iv) urinary
incontinence – according to the parameters used for
evaluation of bowel function in patients with anorectal
malformations (ARM) introduced by Peña [21].
The study was approved by the ethical committee.
Results
A total of 20 patients were included in this study. There
were six (30%) male patients and 14 (70%) female. The
age at presentation ranged from 1 day to 70 days. The
diagnosis was made antenatally in nine patients, at birth
in nine, and after the neonatal period in two. The
diagnosis was made by clinical examination, which
showed the visible external component of tumor in 18
(90%) patients. Plain radiograph showed anterior dis-
placement of the rectum by the tumor in 10 (50%)
patients. Double contrast computed tomography showed
that the rectum was compressed and the urinary bladder
was displaced in 10 (50%) patients. No patients showed
intraspinal extension. Ten (50%) patients were Altman
type I (Fig. 1), seven (35%) were type II (Fig. 2), one
(5%) was type III (Fig. 3), and two (10%) were type IV
(Fig. 4).
Associated congenital anomalies were found in three
(15%) patients. These included imperforate anus (two
cases) and left primary megaureter (one case).
Eighteen (90%) patients were treated on selective basis;
two (10%) patients required urgent intervention, one due
to tumor rupture (Fig. 5) and another due to hemorrhage
inside the tumor (Fig. 6).
Surgical intervention was carried out using a posterior
sacral approach in 17 (75%) patients (all type I and II
patients) (Fig. 7) or combined abdominal and posterior
sacral approaches in the remaining three (types III and
IV) patients (Fig. 8). The tumor was resected en block
with the coccyx in all patients. Spillage due to rupture of
the tumor during dissection occurred in two (10%)
patients.
Fig. 1
Type I sacrococcygeal teratoma.
Fig. 2
Type II sacrococcygeal teratoma.
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Macroscopically, four (20%) cases of our series were solid,
six (30%) were cystic, and 10 (50%) were mixed.
Histopathological examination of the resected tumor
revealed that 15 (75%) patients had grade 0 pathology
(only mature tissue), three (15%) had grade I (rare foci of
immature tissues), one (5%) had grade II (moderate
quantities of immature tissues), and one (5%) had grade
III (large quantities of immature tissue with malignant
yolk sac elements).
Adjuvant chemotherapy was used in one patient proved
to be malignant by histopathological examination.
The follow-up period ranged from 6 months to 5 years.
AFP level measures decreased within 3–9 months. It
became elevated again in recurrent cases. Recurrence
occurred in two patients; these were types III and IV.
Only one (5%) mortality occurred in this series; this case
was an Altman type IV, which was malignant on
histopathological examination (grade III) and received
adjuvant chemotherapy after surgical extirpation.
Ten patients were operated early in this study (during the
period from January 2008 to December 2010, now 3–5
years of age). We lost two of them from follow-up.
Among the remaining eight patients, two (25%) reported
involuntary bowel movements (loss of the ability to feel
the urge to use the toilet and hold the bowel motion until
Fig. 3
Type III sacrococcygeal teratoma.
Fig. 4




Hemorrhage in a sacrococcygeal teratoma.
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reaching the bathroom). Two (25%) patients had
frequent soiling in their underwear during the day and
sometimes during the night. Five (63%) patients reported
constipation; of them, two had soiling and one had
involuntary bowel movements. No patient reported
urinary problems.
The operative scar was satisfactory in all (Fig. 9) but five
(25%) patients who showed hypertrophic ugly scars. All
five patients were having large tumor size.
Discussion
SCT is the most common tumor diagnosed in the
neonate. Approximately, 80% of affected infants are girls,
a 4 : 1 female-to-male preponderance [3]. In our series,
female infants were 70%. This slight difference may be
explained by the relatively small number of patients in
our series.
In this study, associated congenital anomalies were found
in three (15%) patients, two cases of imperforate anus
and one case of left primary megaureter. The reported
incidence in the literature varies widely from 5 to
26% [22–24].
Although described as early as the 19th century, it was
not until the advent of antenatal ultrasonography that
SCTs were diagnosed in utero [25]. The majority of SCTs
Fig. 7
Sacrococcygeal teratoma excision: posterior sacral approach.
Fig. 8
Resection of SCT type III; combined abdominal and posterior sacral approach, (a) abdominal part. (b) the mass is pulled out of the posterior sacral
incision. UB, Urinary bladder.
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present between the 22nd and the 34th week of
gestation. The diagnosis of SCT on routine sonograms is
associated with a greater than expected incidence of
prenatal and perinatal complications [26].
In their published report on their survey among the
members of the American Academy of Pediatrics, Surgical
Section, Altman et al. [6] classified SCTs according to
their extent into four groups: type I (47%), type II (35%),
type III (8%), and type IV (10%). This was comparable
with the incidences in this series.
Antenatal diagnosis is important to avoid complications
during delivery. In the current study, only nine (45%)
patients were diagnosed antenatally. The awareness
among obstetrics–gynecologists regarding the importance
of antenatal diagnosis of these patients is increasing in
our locality. In a previous series, only 20% of cases were
diagnosed antenatally [27].
Roybal et al. [28] recommended preemptive early delivery
by cesarean section when the tumor exceeds the
diameter of 5 cm, to avoid complications such as rupture
and hemorrhage. In the current study, among the nine
patients diagnosed antenatally, five patients had elective
cesarean section because of a large tumor size exceeding
10 cm. One of these patients had hemorrhage and the
tumor size was huge (the baby’s weight was 4 kg, the
tumor weight was 1400 g). This patient was managed on
an urgent basis.
However, one patient with huge SCT (primary manage-
ment was at a peripheral hospital) was not diagnosed
antenatally and underwent vaginal delivery. This patient
had a tumor rupture and underwent urgent operative
intervention.
Macroscopically, four (20%) cases of our series were solid,
six (30%) were cystic, and 10 (50%) were mixed. This
result is in agreement with other results in the
literature [29].
SCTs are graded histologically as follows [30]: grade 0,
tumor contains only mature tissue; grade I, tumor
contains rare foci of immature tissues; grade II, tumor
contains moderate quantities of immature tissues; and
grade III, tumor contains large quantities of immature
tissue with or without malignant yolk sac elements.
Grading of SCTs, unlike that of ovarian teratomas, does
not seem to correlate directly with prognosis [5]. In this
series, the only case proven to be malignant had a grade
III histopathology. However, it is difficult to draw a
conclusion from this association.
The incidence of malignancy in SCTs increases with age.
By the age of 9 months, the incidence of malignancy is
around 70% [31]. In this series, the only case with
malignancy was diagnosed at the age of 3 months.
The primary treatment of SCTs is early surgical resection
with complete excision of the coccyx [9,10]. Adjuvant
chemotherapy is used in malignant cases in the form of
combination of vincristine, actinomycin D, and cyclopho-
sphamide, with or without adriamycin [32]. Early surgical
intervention is associated with better prognosis [9,10]. In
this series, the only patient with malignant disease and
mortality was the one diagnosed and managed lately (at
90 days).
The surgical approach depends on the degree of pelvic
extension [6]. Surgical intervention was carried out using
a posterior sacral approach in 15 (75%) patients (all type I
and II cases) or combined abdominal and posterior sacral
approaches in the remaining three patients (types III and
IV). Intradural invasion of a SCT is a rare variant that has
generally been associated with a favorable neurologic
outcome. However, extension into the spinal canal may
cause paraplegia [8]. We did not encounter any intradural
or intraspinal extension in any of our patients. This is
expected, as intraspinal extension of SCTs is exceedingly
uncommon, being clearly documented in only a few
cases [8].
One case (type IV), primarily managed at a peripheral
hospital, was misdiagnosed as a pelvic abscess and was
evacuated. Recurrence occurred after 3 months, and she
was explored abdominally and the tumor was excised (the
coccyx was not removed). Another recurrence occurred 4
months later (as a retrorectal mass with an external
gluteal part resembling Altman type III). The case was
referred to our institution and had the tumor and coccyx
removed through a combined abdominal and posterior
sacral approach. The patient did well after that, with no
recurrence.
The other case that recurred after excision was a type III
SCT in which spillage of tumor tissue occurred during the
primary operation.
Of the eight patients in this series who are still followed
up as an outpatient and who are at least 3 years of age,
two (25%) patients reported involuntary bowel move-
ments (loss of the ability to feel the urge to use the toilet
and hold the bowel motion until reaching the bathroom).
Fig. 9
Satisfactory scar of excision.
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These two patients were Altman types II and III. Two
(25%) patients had frequent soiling in their underwear
during the day and sometimes during the night. These
two patients were Altman types II and III. Five (63%)
patients reported constipation; of them, two patients had
soiling and one had involuntary bowel movements. These
patients were Altman types II and III. No patient
reported urinary problems. Bowel complications corre-
lated with the Altman’s classification. All of them
occurred in types II and III. No such complications
occurred in type I SCT. This result contradicts the one
reported by Derikx et al. [33] who found no correlation
between these complications and Altman’s classification.
The incidence is a bit high; however, it should be noted
that this is not the overall incidence but rather the
incidence among the eight patients who were regular in
long-term follow-up.
Conclusion
SCT is a common neonatal neoplasm. Awareness about
this pathology among practitioners is essential, especially
antenatal diagnosis, and would have avoided complica-
tions in this series. In addition, delivery in a tertiary
hospital by cesarean section, when needed, should be
emphasized. Early diagnosis and complete excision with
removal of the coccyx is associated with good prognosis.
Recurrence is related to tumor spillage during excision,
incomplete resection, and leaving the coccyx behind.
Long-term lower gastrointestinal problems (constipation,
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